Effects of estrogen with and without progestin and obesity on symptomatic gastroesophageal reflux

Zongli Zheng, Karen L Margolis, Simin Liu, Lesley F Tinker, Weimin Ye, Women's Health Initiative Investigators, Elizabeth Nabel, Jacques Rossouw, Shari Ludlam, Linda Pottern, Joan McGowan, Leslie Ford, Nancy Geller, Ross Prentice, Garnet Anderson, Andrea LaCroix, Charles L Kooperberg, Ruth E Patterson, Anne McTiernan, Sally Shumaker, Evan Stein, Steven Cummings, Sylvia Wassertheil-Smoller, Aleksandar Rajkovic, JoAnn Manson, Annlouise R Assaf, Lawrence Phillips, Shirley Beresford, Judith Hsia, Rowan Chlebowski, Evelyn Whitlock, Bette Caan, Jane Morley Kotchen, Barbara V Howard, Linda Van Horn, Henry Black, Marcia L Stefanick, Dorothy Lane, Rebecca Jackson, Cora E Lewis, Tamsen Bassford, Jean Wactawski-Wende, John Robbins, F Allan Hubbell, Lauren Nathan, Robert D Langer, Margery Gass, Marian Limacher, David Curb, Robert Wallace, Judith Ockene, Norman Lasser, Mary Jo O'Sullivan, Karen Margolis, Robert Brunner, Gerardo Heiss, Lewis Kuller, Karen C Johnson, Robert Brzyski, Gloria E Sarto, Denise Bonds, Susan Hendrix, Zongli Zheng, Karen L Margolis, Simin Liu, Lesley F Tinker, Weimin Ye, Women's Health Initiative Investigators, Elizabeth Nabel, Jacques Rossouw, Shari Ludlam, Linda Pottern, Joan McGowan, Leslie Ford, Nancy Geller, Ross Prentice, Garnet Anderson, Andrea LaCroix, Charles L Kooperberg, Ruth E Patterson, Anne McTiernan, Sally Shumaker, Evan Stein, Steven Cummings, Sylvia Wassertheil-Smoller, Aleksandar Rajkovic, JoAnn Manson, Annlouise R Assaf, Lawrence Phillips, Shirley Beresford, Judith Hsia, Rowan Chlebowski, Evelyn Whitlock, Bette Caan, Jane Morley Kotchen, Barbara V Howard, Linda Van Horn, Henry Black, Marcia L Stefanick, Dorothy Lane, Rebecca Jackson, Cora E Lewis, Tamsen Bassford, Jean Wactawski-Wende, John Robbins, F Allan Hubbell, Lauren Nathan, Robert D Langer, Margery Gass, Marian Limacher, David Curb, Robert Wallace, Judith Ockene, Norman Lasser, Mary Jo O'Sullivan, Karen Margolis, Robert Brunner, Gerardo Heiss, Lewis Kuller, Karen C Johnson, Robert Brzyski, Gloria E Sarto, Denise Bonds, Susan Hendrix

Abstract

Background & aims: An association between female hormones and symptomatic gastroesophageal reflux disease (GERD) and may be modified by obesity is suggested but not proven. Factors affecting GERD progression, however, are largely unknown.

Methods: At 40 US clinical centers, postmenopausal women with hysterectomy (n = 10,739) were randomly assigned to receive 0.625 mg/d of conjugated equine estrogens or placebo. Women without hysterectomy (n = 16,608) were randomly assigned to receive estrogen plus progestin, given as 0.625 mg conjugated equine estrogens/d plus 2.5 mg medroxyprogesterone acetate/d, or placebo. We performed secondary analyses using data from these trials.

Results: After 1 year, there was a trend toward a higher incidence of symptomatic GER among women randomly assigned to the estrogen treatment (4.2%) than with placebo (3.1%). The estrogen plus progestin treatment did not affect this risk. Neither treatment affected the progression of existing GER symptom. There was a dose-response association between baseline obesity, particularly as measured by waist circumference, with more than double the risk of incident symptomatic GER at 1 year among women with the largest waist circumference (>or=114 cm) compared with a normal waist circumference (70-80 cm). Weight gain at 1 year was associated with elevated risk of incident symptomatic GER. Weight loss at 1 year alleviated existing GER symptoms. No interaction between hormone therapy and obesity on symptomatic GER was observed.

Conclusions: Estrogen treatment alone, but not with progestin, may cause GER symptoms in postmenopausal women. Increasing weight and girth increases the risk of developing GER symptoms, whereas weight loss alleviates existing GER symptoms. This trial was registered at www.clinicaltrials.gov as NCT00000611.

Conflict of interest statement

All authors declare that they have no conflict of interest to disclose.

Figures

Figure 1
Figure 1
Flow diagram of women included in the analyses.

Source: PubMed

3
Suscribir